Affordable Access

deepdyve-link
Publisher Website

Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial.

Authors
  • Cairo, Mitchell S1, 2, 3, 4, 5
  • Talano, Julie-An6
  • Moore, Theodore B7
  • Shi, Qiuhu8
  • Weinberg, Rona Singer9
  • Grossman, Brenda10
  • Shenoy, Shalini11
  • 1 Department of Pediatrics, New York Medical College, Valhalla.
  • 2 Department of Medicine, New York Medical College, Valhalla.
  • 3 Department of Pathology, New York Medical College, Valhalla.
  • 4 Department of Microbiology & Immunology, New York Medical College, Valhalla.
  • 5 Department of Cell Biology & Anatomy, New York Medical College, Valhalla.
  • 6 Department of Pediatrics, Medical College of Wisconsin, Milwaukee.
  • 7 Department of Pediatrics, University of California, Los Angeles, Los Angeles.
  • 8 Department of Epidemiology & Community Health, New York Medical College, Valhalla.
  • 9 The New York Blood Center, New York.
  • 10 Department of Pathology & Immunology, Washington University in St Louis, St Louis, Missouri.
  • 11 Department of Pediatrics, Washington University in St Louis, St Louis, Missouri.
Type
Published Article
Journal
JAMA pediatrics
Publication Date
Feb 01, 2020
Volume
174
Issue
2
Pages
195–197
Identifiers
DOI: 10.1001/jamapediatrics.2019.4715
PMID: 31816036
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times